Fundraising FoxAbell Foundation, Inc. — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Irazu Oncologyirazuoncology.cominNov 2023
Irazú Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens.
BiotechHealthtechMedical DevicesBaltimore, US
Jeff Strovel(Chief Executive Officer)inJames Berens(Executive Officer)Richard Kohr(Executive Officer)Jeffrey Strovel, PhD(Chief Executive Officer)in
Co-investorsMaryland TEDCOTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.